Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of benzodioxoles and oxadiazoles. It has been identified as an experimental inhibitor of glycogen synthase kinase‐3 beta (GSK‐3β), with an IC50 value of approximately 65 nM. GSK‐3β is a serine/threonine kinase involved in various cellular processes including metabolism and cell signaling. The compound has not been approved for any indication and there are no registered clinical trials or marketed products associated with it[1][2][7]. Its primary research interest is as a tool compound for studying GSK‐3β inhibition.
- Other names
- 2-(1,3-benzodioxol-5-yl)-5-(3-fluoro-4-methoxybenzylsulfanyl)-1,3,4,-oxadiazole2-(Benzo[d][1,3]dioxol‑5‑yl)‑5‑((3‑fluoro‑4‑methoxybenzyl)thio)‑1,3,4‑oxadiazole
02
Targets
GSK3 (Glycogen synthase kinase 3 beta)
Beyond the preview
Go deeper on 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole.